v3.24.2.u1
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
OPERATING EXPENSES-        
RESEARCH AND DEVELOPMENT EXPENSES $ 1,348,985 $ 1,879,519 $ 5,010,618 $ 6,186,039
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES 2,486,846 1,359,782 7,025,503 5,507,511
Total operating expenses 3,835,831 3,239,301 12,036,121 11,693,550
OPERATING LOSS (3,835,831) (3,239,301) (12,036,121) (11,693,550)
OTHER INCOME (EXPENSE), NET        
Interest income 30,619 23,511 126,872 114,325
Interest expense (298,248) 0 (1,038,499) (389,626)
Other (expense) 0 (384,137) 0 (384,137)
Total other expense, net (267,629) (360,626) (911,627) (659,438)
LOSS BEFORE INCOME TAXES (4,103,460) (3,599,927) (12,947,748) (12,352,988)
Income tax expense 0 0 0 0
NET LOSS (4,103,460) (3,599,927) (12,947,748) (12,352,988)
Deemed dividends on Series C and D Preferred Stock (100,045) (3,337,494) (262,283) (3,337,494)
Common stock dividends on Series D Preferred Stock 0 (1,627,230) 0 (1,627,230)
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS $ (4,203,505) $ (8,564,651) $ (13,210,031) $ (17,317,712)
Basic and diluted loss per share $ (0.05) $ (0.18) $ (0.16) $ (0.36)
Weighted average shares of common stock outstanding- basic and diluted 83,038,866 48,928,911 82,314,925 48,604,274

Source